Clinical Trials Logo

Ocular Motility Disorders clinical trials

View clinical trials related to Ocular Motility Disorders.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT05070767 Completed - Headache Clinical Trials

Neurolens Headache Study

Start date: October 18, 2021
Phase: N/A
Study type: Interventional

To understand the benefits of the neurolens Measurement Device and neurolens treatment as it pertains to treating symptoms related to Chronic Headaches. It is a Prospective randomized double masked two arm performed on a minimum of 200 to a maximum of 300 subjects identified as symptomatic (HIT-6 questionnaire score equal to or greater than 56) done across 3-15 clinical sites. There are two subgroups: a minimum of 100 in each subgroup (subgroup 1: pre-presbyopic (18-40 years); subgroup 2: presbyopic subjects (41-60 years).

NCT ID: NCT04064112 Completed - Clinical trials for Convergence Insufficiency Intermittent Exotropia (CI-IXT)

S-BLR Versus C-BLR for CI-IXT in Children

SCCIXT
Start date: October 18, 2019
Phase: N/A
Study type: Interventional

This is a multi-center, randomized single-blind controlled trial to compare the effectiveness of S-BLR with C-BLR for the treatment of CI-IXT in children. Specific Aim 1 (Primary): To compare the surgical successful rate of S-BLR with C-BLR for the treatment of CI-IXT in children. Specific Aim 2 (Secondary): To study the suboptimal surgical outcomes between S-BLR and C-BLR for the treatment of CI-IXT in children.

NCT ID: NCT03593031 Completed - Clinical trials for Convergence Insufficiency

Neural Mechanism of Vision Therapy for Patients With Convergence Insufficiency

Start date: April 1, 2014
Phase: N/A
Study type: Interventional

Convergence insufficiency (CI) is a prevalent binocular vision disorder with symptoms that include double/blurred vision, eyestrain, and headaches when engaged in reading or other near work. CI is present in 4% of the population where approximately 27% of CI patients do not improve even with validated therapy. The project will quantitatively study changes in convergence eye movements and neural substrates before and after validated therapy in CI patients. This knowledge can lead to improvements in currently validated therapy, reduction in therapy sessions, and reduced healthcare costs.

NCT ID: NCT03319966 Completed - Clinical trials for Mild Traumatic Brain Injury

Eyetracking and Neurovision Rehabilitation of Oculomotor Dysfunction in Mild Traumatic Brain Injury

Start date: October 18, 2017
Phase:
Study type: Observational

The purpose of this single center, longitudinal, pilot study is to provide evidence for the use of an eye tracking system as an objective tool to identify mild traumatic brain injury (mTBI) related oculomotor dysfunction (OMD) and predict the effectiveness of neurovision rehabilitation (NVR) of OMD. Eye tracking visual stimulus measurements will be compared to objective developmental optometrist (OD) diagnosis and assessments. It will be determined whether an eye tracking system can predict the presence or absence of mTBI related OMD and whether mTBI patients who have OMD based on the eye tracking system will respond positively to NVR.

NCT ID: NCT02981875 Completed - Clinical trials for Ocular Motility Disorders

Oculomotor Training Improves Reading Eye Movement

Start date: January 1, 2015
Phase: N/A
Study type: Interventional

Children with reading eye movement problems were recruited for this study. The treatment group was provided with oculomotor training for 8 weeks, the control group was given placebo exercises.

NCT ID: NCT02607384 Completed - Refractive Error Clinical Trials

The Baltimore Reading and Eye Disease Study

BREDS
Start date: November 2014
Phase: N/A
Study type: Interventional

The Baltimore Reading and Eye Disease Study (BREDS) is a two year study to determine the prevalence of vision problems in an early school age population with reading difficulty. Comprehensive vision and reading tests will be administered to 400 students at participating schools in the Baltimore City Public School system. A secondary goal is to examine the impact of vision treatment on reading performance. Children with refractive error or convergence insufficiency will be provided treatment free of charge. The investigators will evaluate the impact that the treatment has on vision function and reading performance.

NCT ID: NCT02510040 Completed - Clinical trials for Convergence Insufficiency

A Prospective Observational Study of Adult Strabismus

SAS1
Start date: August 17, 2015
Phase:
Study type: Observational

The purpose of this study is to describe clinical characteristics, treatments, and one-year outcomes of adults with convergence insufficiency, divergence insufficiency, or small angle hypertropia.

NCT ID: NCT02391961 Completed - Multiple Sclerosis Clinical Trials

Study and Treatment of Visual Dysfunction and Motor Fatigue in Multiple Sclerosis

Start date: April 1, 2015
Phase: Phase 2
Study type: Interventional

Primary fatigue represents a major cause of disability in patients with multiple sclerosis (MS), being reported in about 90% of cases. Fatigue interferes with everyday functioning but, unfortunately, little is known about its mechanisms. The investigators propose a characteristic eye movement abnormality (internuclear ophthalmoparesis, INO), commonly encountered in MS, as a simple model for primary motor fatigue. The investigators described worsening of ocular performance in MS patients with INO following visual tasks (ocular motor fatigue), which is likely due to decreased neural conduction along brain pathways injured by MS. This mechanism could represent a major component of MS-related primary motor fatigue. Relevant to Veterans' care, INO is a significant cause of visual disability, especially when complicated by ocular fatigue, and limits daily activities such as reading and driving. The investigators propose a medical treatment to improve ocular performance/fatigue in INO, which can reduce visual disability and improve quality of life in Veterans with MS.

NCT ID: NCT02251002 Completed - Clinical trials for TBI (Traumatic Brain Injury)

Frontoparietal Priority Maps as Biomarkers for MTBI

Start date: July 2015
Phase:
Study type: Observational

The purpose of this study is to determine whether there is a quantitative relationship between brain processes seen by a MRI and visual deficits caused by mild to moderate traumatic brain injuries (mTBI).

NCT ID: NCT01515943 Completed - Clinical trials for Convergence Insufficiency

Convergence Insufficiency Treatment Study (CITS)

Start date: June 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the effectiveness of home-based computer therapy for symptomatic convergence insufficiency (CI) compared to traditional home-based near target push-ups and placebo treatment.